201 related articles for article (PubMed ID: 38423815)
1. Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds.
Yan H; Peng Y; Zhang J; Peng R; Feng X; Su J; Yi H; Lu Y; Gao S; Liu J; Yang M; Liu X; Gao S; Chen Z
Vaccine; 2024 Mar; 42(8):2072-2080. PubMed ID: 38423815
[TBL] [Abstract][Full Text] [Related]
2. Potent immune responses against thermostable Foot-and-Mouth disease virus VP1 nanovaccine adjuvanted with polymeric thermostable scaffold.
Peng Y; Yan H; Zhang J; Peng R; Feng X; Su J; Yi H; Lu Y; Chen Z
Vaccine; 2024 Feb; 42(4):732-737. PubMed ID: 38220487
[TBL] [Abstract][Full Text] [Related]
3. A rapid and sensitive fluorescent chromatography with cloud system for MPXV point-of-care diagnosis.
Yan H; Su J; Tian L; Li Q; Feng X; Zhang J; Shi Y; Liao C; Liu J; Gao S; Yang M; Liu X; Lu J; Chen Z
Anal Chim Acta; 2024 May; 1302():342514. PubMed ID: 38580408
[TBL] [Abstract][Full Text] [Related]
4. Rational development of multicomponent mRNA vaccine candidates against mpox.
Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF
Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428
[TBL] [Abstract][Full Text] [Related]
5. Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein.
Cai JP; Chu WM; Tam AR; Wang K; Han Y; Chen LL; Zhang X; Choi CY; Cheng VC; Chan KH; Chen Z; Hung IF; Fong CH; To KK
Commun Med (Lond); 2023 Nov; 3(1):168. PubMed ID: 37993690
[TBL] [Abstract][Full Text] [Related]
6. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
Zuiani A; Dulberger CL; De Silva NS; Marquette M; Lu YJ; Palowitch GM; Dokic A; Sanchez-Velazquez R; Schlatterer K; Sarkar S; Kar S; Chawla B; Galeev A; Lindemann C; Rothenberg DA; Diao H; Walls AC; Addona TA; Mensa F; Vogel AB; Stuart LM; van der Most R; Srouji JR; Türeci Ö; Gaynor RB; Şahin U; Poran A
Cell; 2024 Mar; 187(6):1363-1373.e12. PubMed ID: 38366591
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice.
Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X
Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226
[TBL] [Abstract][Full Text] [Related]
8. Thermostable T Cell Multiepitope Nanoparticle Antigens Inducing Potent Immune Responses against the Swine Fever Virus.
Sun L; Niu J; Zhang J; Peng Y; Feng X; Huang F; Liu J; Li S; Chen Z
ACS Infect Dis; 2023 Nov; 9(11):2358-2368. PubMed ID: 37861250
[TBL] [Abstract][Full Text] [Related]
9. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
[TBL] [Abstract][Full Text] [Related]
10. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.
Zeng J; Li Y; Jiang L; Luo L; Wang Y; Wang H; Han X; Zhao J; Gu G; Fang M; Huang Q; Yan J
Emerg Microbes Infect; 2023 Dec; 12(1):2204151. PubMed ID: 37070521
[TBL] [Abstract][Full Text] [Related]
11. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.
Xia H; He YR; Zhan XY; Zha GF
Antiviral Res; 2023 Aug; 216():105668. PubMed ID: 37429529
[TBL] [Abstract][Full Text] [Related]
12. Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida.
Kupritz J; Pahwa S; Pallikkuth S
Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003819
[TBL] [Abstract][Full Text] [Related]
13. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.
Ye T; Zhou J; Guo C; Zhang K; Wang Y; Liu Y; Zhou J; Xie Y; Li E; Gong R; Zhang J; Chuai X; Chiu S
Cell Rep; 2024 Jun; 43(6):114269. PubMed ID: 38787725
[TBL] [Abstract][Full Text] [Related]
14. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
[TBL] [Abstract][Full Text] [Related]
15. Progress and prospects on vaccine development against monkeypox infection.
Saadh MJ; Ghadimkhani T; Soltani N; Abbassioun A; Daniel Cosme Pecho R; Taha A; Jwad Kazem T; Yasamineh S; Gholizadeh O
Microb Pathog; 2023 Jul; 180():106156. PubMed ID: 37201635
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J
J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population.
Li M; Guo Y; Deng Y; Gao W; Huang B; Yao W; Zhao Y; Zhang Q; Huang M; Liu M; Li L; Guo P; Tian J; Wang X; Lin Y; Gan J; Guo Y; Hu Y; Zhang J; Yang X; Shang B; Yang M; Han Y; Wang Y; Cong P; Li M; Chu Q; Zhang D; Wang Q; Zhang T; Wu G; Tan W; Gao GF; Liu J
Cell Rep; 2024 Jan; 43(1):113609. PubMed ID: 38159277
[TBL] [Abstract][Full Text] [Related]
18. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development.
Andrei G; Snoeck R
Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695
[TBL] [Abstract][Full Text] [Related]
19. Stability of mpox virus on different commonly contacted surfaces.
Li F; Shen X; Zhang H; Jin H; Zhang L; Lv B; Li W; Liang Z; Zhang X; Zhang D; Hou X; Pan Y; Kan B; Wang Q
J Med Virol; 2023 Dec; 95(12):e29296. PubMed ID: 38054540
[TBL] [Abstract][Full Text] [Related]
20. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
Morino E; Mine S; Tomita N; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Terada J; Ainai A; Sakai Y; Park E; Seki S; Akazawa D; Shimojima M; Shiwa-Sudo N; Virhuez-Mendoza M; Miyauchi K; Moriyama S; Iwata-Yoshikawa N; Harada M; Harada S; Hishiki T; Kotaki R; Matsumura T; Miyamoto S; Kanno T; Isogawa M; Watashi K; Nagata N; Ebihara H; Takahashi Y; Maeda K; Matano T; Wakita T; Suzuki T; Sugiura W; Ohmagari N; Ujiie M
NEJM Evid; 2024 Mar; 3(3):EVIDoa2300290. PubMed ID: 38411447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
